Figure 1.
Increased allergen-driven asthmatic inflammation in OVA-challenged Nrf2 −/− mice. (A) Total and differential inflammatory cell populations in the BAL fluid of OVA- and saline-challenged Nrf2 + / + and Nrf2 − / − mice (n = 8). (B) First challenge with OVA. (C) Second challenge with OVA. (D and E) Third challenge with OVA. There was a progressive increase in the total number of inflammatory cells in the BAL fluid of both OVA-challenged Nrf2 + / + and Nrf2 − / − mice from the first to third challenges. However, the number of inflammatory cells in the BAL fluid of Nrf2−/ − OVA mice was significantly higher than in the BAL fluid of Nrf2 + / + OVA mice, as well as the respective saline-challenged mice. The number of eosinophils, lymphocytes, neutrophils, and epithelial cells were significantly (*) higher in the BAL fluid of Nrf2 − / − OVA mice compared with Nrf2 + / + OVA mice. Pretreatment with NAC significantly (*) reduced the inflammatory cells (F), predominantly eosinophils (G), in the BAL fluid of Nrf2 − / − OVA mice (n = 6). Data are mean ± SEM. *, P ≤ 0.05.